1st Quarter - Report

REPRODUCTIVE FREEDOM FOR ALL for REPRODUCTIVE FREEDOM FOR ALL

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$10,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2021 $10,000 Replaced
1st Quarter - Amendment Mar 4, 2022 $40,000 Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Foreign Relations FOR

Restrictions on the use of U.S. foreign aid for abortion care and expansion to global health contracts; H.R. 1378, Abortion is Healthcare Everywhere Act, regarding foreign aid for health care organizations; H.R. 556 and S. 142, Global HER Act, regarding foreign aid for health care organizations.

LobbyistCovered position, as disclosed
CHRISTINA KRYSINSKI —
KATE RYAN —
AMY WILLIAMS NAVARRO —
STEPHANIE YOST —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA)

Bills named: H.R. 1378 (117th), H.R. 556 (117th), S. 142 (117th)

Budget/Appropriations BUD

Reproductive healthcare in federal spending bills and the presidential budget; H.R.1319, American Rescue Plan Act, regarding restrictions on reproductive health care and coverage; S.Con.Res. 5, budget reconciliation bill, regarding restrictions on reproductive health care and coverage; Lee Amendment (#821) to S.Con.Res. 5; Sasse Amendment (#192) to S.Con.Res. 5; Lankford Amendment (#1031) to H.R.1319.

LobbyistCovered position, as disclosed
CHRISTINA KRYSINSKI —
KATE RYAN —
AMY WILLIAMS NAVARRO —
STEPHANIE YOST —

Contacted: Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; SENATE

Bills named: S.Con.Res. 5 (117th), H.R. 1319 (117th)

Family issues/Abortion/Adoption FAM

Reproductive Rights and Roe v. Wade; Access to the full spectrum of abortion care options; State abortion bans and abortion access in the United States; Access to abortion and contraception for veterans, servicemembers, and dependents; Access to the contraceptive coverage benefit under the Affordable Care Act; Trump administration refusal of care rule; Maternal health outcomes and care options; Treatment of pregnant incarcerated people and detainees; COVID-19 response efforts, including federal relief response, paid family leave, and restrictions on insurance coverage of abortion; H.R. 2234 and S. 1021, EACH Act, regarding access to affordable health insurance plans that cover abortion; H.R.804 and S.248, FAMILY Act, regarding paid family leave; H.R.959, the Momnibus Act, regarding maternal health outcomes; H.R. 666 and S. 162, Anti-Racism in Public Health Act, regarding strengthening the federal governments ability to develop anti-racist health policy; H.R. 1065 the Pregnant Workers Fairness Act, regarding discrimination against pregnant workers; H.J.Res. 17, Resolution to remove the deadline for ratification of the Equal Rights Amendment; H.R. 1378, Do No Harm Act, regarding denials of care; H.R. 5 and S. 393, the Equality Act, regarding ending discrimination for LGBTQIA+ individuals.

LobbyistCovered position, as disclosed
CHRISTINA KRYSINSKI —
KATE RYAN —
AMY WILLIAMS NAVARRO —
STEPHANIE YOST —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA)

Bills named: S. 1021 (117th), S. 162 (117th), H.R. 5 (117th), H.R. 666 (117th), S. 248 (117th), H.R. 1378 (117th), H.R. 804 (117th), H.J.Res. 17 (117th), S. 393 (117th), H.R. 959 (117th), H.R. 2234 (117th), H.R. 1065 (117th)

Government Issues GOV

Federal courts and judicial nominees; Executive branch nominations; Nomination of Xavier Becerra to be Secretary of Health and Human Services; Nomination of Neera Tanden to be Director of the Office of Management and Budget; Nomination of Marty Walsh to be the Secretary of Labor; Nomination of Merrick Garland to be Attorney General; Nomination of Vanita Gupta to be Associate Attorney General; Nomination of Kristen Clarke to be Associate Attorney General; Nomination of Rachel Levine to be Assistant Secretary of Health and Human Services; Nomination of Shalanda Young to be Director of the Office of Management and Budget; Nomination of Antony Blinken to be Secretary of State; Nomination of Linda Thomas Greenfeld to be Ambassador to the United Nations; Nomination of Samantha Power to be Administrator of U.S. Agency for International Development; H.R. 51, Washington D.C. Admission Act, regarding statehood for Washington, D.C.; H.Res. 24, Article of Impeachment, regarding the impeachment of President Donald Trump.

LobbyistCovered position, as disclosed
CHRISTINA KRYSINSKI —
KATE RYAN —
AMY WILLIAMS NAVARRO —
STEPHANIE YOST —

Contacted: Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE

Bills named: H.R. 51 (117th), H.Res. 24 (117th)

Immigration IMM

H.R.6, American Dream and Promise Act, regarding a pathway to citizenship for undocumented immigrant youth; H.R. 1603, Farm Workforce Modernization Act of 2021, regarding a pathway to citizenship for undocumented farm workers and their immediate families.

LobbyistCovered position, as disclosed
CHRISTINA KRYSINSKI —
KATE RYAN —
AMY WILLIAMS NAVARRO —
STEPHANIE YOST —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 6 (117th), H.R. 1603 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.